Pharmaceutical Report Library l Report Store l Pharma Intelligence

MedTech analysis
Special bundles
Strategy analysis
Strategy analysis
Disease analysis
Company analysis
Drug analysis
MedTech analysis

Text search

Sort by Popularity (sales)

Display 15 Products per page

Digital Pharma: Are We Nearly There?

$2,995.00

Digital’s potential to transform every aspect of the pharmaceutical value chain, from discovery to commercial, is widely documented.
August 14, 2018
Find out more
Japan Pharma Outlook 2027

$3,000.00

PharmaVitae explores and visualizes market dynamics in the Japan Pharma peer set out to 2027* through analysis and in-house sales forecasts for more than 320 products.
July 2, 2018
Find out more
Market Spotlight: Hidradenitis Suppurativa

$1,318.00

All of the approved drugs for hidradenitis suppurativa (HS) target tumor necrosis factor-alpha. These therapies are administered via the subcutaneous route, while Humira and Yuflyma are also available in intravenous formulations.
September 8, 2022
Find out more
Market Spotlight: Thyroid Cancer

$1,318.00

This Market Spotlight report covers the Thyroid Cancer market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability of success, and a 10-year disease incidence and five-year prevalence forecast, as well as presenting drug-specific revenue forecasts.
August 23, 2022
Find out more
Market Spotlight: Duchenne Muscular Dystrophy (DMD)

$1,318.00

This Market Spotlight report covers the Duchenne Muscular Dystrophy (DMD) market, comprising key marketed and pipeline drugs, clinical trials, upcoming events, a 10-year disease prevalence forecast, probability of success, recent events and analyst opinion, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
September 15, 2022
Find out more
Market Spotlight: Celiac Disease

$1,318.00

Datamonitor Healthcare estimates that in 2019, there were approximately 121.1 million seropositive prevalent cases of celiac disease and 48.0 million prevalent cases of biopsy-proven celiac disease worldwide.
September 8, 2022
Find out more
Market Spotlight: Sickle Cell Anemia

$1,318.00

This Market Spotlight report covers the Sickle Cell Anemia market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability of success, a 10-year disease prevalence forecast, and licensing and acquisition deals.
August 25, 2022
Find out more
Clinical Trial Strategies in Biosimilar Drug Development

$2,995.00

As the patent cliff for many blockbuster biologic therapies is approaching, clinical development programs for biosimilar options to those therapies are emerging at a rapid pace.
October 13, 2017
Find out more
Market Spotlight: Small-Cell Lung Cancer (SCLC)

$1,318.00

This Market Spotlight report covers the Small Cell Lung Cancer (SCLC) market, comprising key marketed and pipeline drugs, recent events and analyst opinion, probability of success, clinical trials, upcoming and regulatory events, a 10-year disease incidence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
October 26, 2022
Find out more
Market Spotlight: Amyotrophic Lateral Sclerosis (ALS)

$1,318.00

This Market Spotlight report covers the Amyotrophic Lateral Sclerosis (ALS) market, comprising key marketed and pipeline drugs, clinical trials, upcoming and regulatory events, recent events and analyst opinion, a 10-year disease incidence forecast, probability of success, and licensing and acquisition deals.
October 6, 2022
Find out more
Big Pharma Outlook 2026

$2,700.00

Using in-house sales forecasts, this analysis explores and visualizes market dynamics in the Big Pharma peer set out to 2025.
June 29, 2017
Find out more
Global Diabetes Management Devices Market

$4,750.00

The global market for diabetes management devices—valued at more than $9bn in 2015—is a substantial, highly competitive market driven by highly sophisticated, evolving technology, particularly in the insulin pump/artificial pancreas and CGM area.
March 30, 2017
Find out more
Mid Pharma Licensing and M&A Trends, 2011–16

$2,995.00

This analysis covers trends in alliance and mergers and acquisitions (M&A) agreements by Datamonitor Healthcare’s Mid Pharma peer set from 1 January 2011 through to 30 September 2016. Only deals involving drug discovery, development, or commercialization were considered for this analysis. All data were derived from Informa’s Strategic Transactions and Medtrack databases.
February 16, 2017
Find out more
CMO Market Dynamics and Strategies

$5,000.00

Commoditization in the CMO market is driving the leading players to niche services. The sector is struggling to deliver consistent growth.
November 3, 2016
Find out more
An Evolution in Partnering: Can CROs Lead the Way in Innovation?

$5,000.00

The concept of a drug development partnership between CRO and sponsor is the latest strategic evolution in the search for efficiency and innovation in the biopharmaceutical world.
November 3, 2016
Find out more

Report library

Digital Pharma: Are We Nearly There?

Japan Pharma Outlook 2027

Market Spotlight: Hidradenitis Suppurativa

Market Spotlight: Thyroid Cancer

Market Spotlight: Duchenne Muscular Dystrophy (DMD)

Market Spotlight: Celiac Disease

Market Spotlight: Sickle Cell Anemia

Clinical Trial Strategies in Biosimilar Drug Development

Market Spotlight: Small-Cell Lung Cancer (SCLC)

Market Spotlight: Amyotrophic Lateral Sclerosis (ALS)

Big Pharma Outlook 2026

Global Diabetes Management Devices Market

Mid Pharma Licensing and M&A Trends, 2011–16

CMO Market Dynamics and Strategies

An Evolution in Partnering: Can CROs Lead the Way in Innovation?